Clinical trial begins for an experimental drug for opioid cravings
The National Institutes of Health Clinical Center has begun a research on a drug developed to deal with the cravings linked with opioid use. The clinical trial would test the safety of the active compound in the drug, ANS-6637, in healthy individuals. It would also look at how the body processes the drug when administered with an additional drug metabolized by similar liver enzymes. The trial is being conducted with the help of NIH’s National Institute of Allergy and Infectious Diseases (NIAID), and funded by the NIH’s Helping to End Addiction Long-Term (HEAL) Initiative. This is an extensive program to fast-track the research endeavors to curtail the opioid epidemic, which has become a public health crisis. Read more